/Companies

Nanophoria

4 known investors

Find your way into Nanophoria

354 people in our graph can introduce you to the Nanophoria team.

Sign up to see every warm intro you have to Nanophoria

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanophoria team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.

Founders & leadership

DCDaniele Catalucci
Daniele CatalucciDaniele Catalucci leads translational cardiovascular research at NanoPhoria, focusing on cardiac disease mechanisms through approaches including RNA regulation, peptide therapies, and nanotechnology-enabled platforms. His work integrates molecular biology, biochemistry, and functional assays to develop treatments for heart failure.
MIMichele Iafisco
Michele Iafisco
AAAlessio Alogna
Alessio Alogna
CDClaudio De Luca
Claudio De LucaClaudio De Luca is a life sciences executive with 25 years of experience in MedTech and BioTech, including roles across product development, clinical validation, regulatory approval, and commercialization of biomedical products.

Investors · 4

Frequently asked questions

What does Nanophoria do?
NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.
Who founded Nanophoria?
Nanophoria was founded by Daniele Catalucci, Michele Iafisco.
Who are Nanophoria's investors?
Nanophoria's investors include Sofinnova Partners, XGEN Venture, CDP Venture Capital, European Innovation Council Fund.